Answers are grounded in this paper and cite their sources.
Wound healing remains a clinical challenge, and bioactives from Amazonian biodiversity require suitable delivery systems to be effective. Hyptis crenata essential oil is a promising bioactive, exhibiting low acute toxicity and significant anti-inflammatory properties. Chitosan is a versatile biopolymer widely explored for wound dressings because of its biocompatibility, biodegradability, and antimicrobial properties. Hence, chitosan membranes containing 0.5, 2.5, and 5.0% (w/w) of Hyptis crenata essential oil (rich in 1,8-cineole (35.9%), α-pinene (20.8%), camphor (10.0%), and β-pinene (7.3%)) were produced and evaluated in vitro and in vivo. Mucoadhesion strength (0.145–0.161 N) remained consistent with essential oil addition. Essential oil did not alter membrane morphology or significantly affect mechanical properties, with Young’s modulus values (4.19–4.80 MPa) remaining within the reported range for human skin (0.02–57 MPa). Fourier Transform Infrared Spectroscopy suggested interactions between the chitosan chains and essential oil and showed thermal stability, preventing oil decomposition. In vitro, Hyptis crenata essential oil–incorporated chitosan membranes significantly reduced nitrite levels and decreased tumor necrosis factor-α in Lipopolysaccharide-stimulated macrophages, especially at lower essential oil concentrations. In vivo, CH/HcEO membranes significantly increased wound closure compared with the untreated control on day 7, reaching 73.8% and 95.4% closure on days 7 and 14, respectively. Overall, Hyptis crenata essential oil–incorporated chitosan represent a promising wound dressing strategy, combining cytocompatibility, anti-inflammatory effects, and enhanced healing.
No takes yet. Share an insight, caveat, or question.
Buriti et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: